Alisa Peinhardt, MAIS, BSN

Program Manager - Infectious Disease Clinical Trials Group
University of Alabama at Birmingham

Disclosure: Mycoses Study Group Education and Research Consortium (Individual(s) Involved: Self): Consultant

Presentation(s):

• 144 - MSG-15: Pharmacokinetic (PK), Adverse Events (AEs), and Tolerability Data from an Open Label Randomized Clinical Trial (RCT) Comparing Oral Suba-itraconazole (SUBA-ITC) to Conventional Itraconazole (C-ITC) for Treatment of Endemic Mycosis (EM)

  Oral Abstract